EWEdwards Lifesciences
Edwards Lifesciences Corporation is the leading global structural heart innovation company, driven by a passion to improve patient lives. 10-K, Item 1
- Employees
- 16,000
- Headquarters
- Irvine, CA
- CEO
- Bernard J. Zovighian
- Next results
- around Feb 9, 2027
The numbers EW said it expected, in its earnings releases of the last 3 years, next to what it then reported for the same period. Each target links to the sentence in the release; each result to the 10-Q or 10-K it was first reported in.
Of 8 range targets with a reported result: 4 came in above the last range given, 2 within it, 2 below it.
| Target | What the company said | Reported | Result |
|---|---|---|---|
| Diluted EPS Fiscal 2026 |
Given $2.90 to $3.05 release 2026-02-10
|
– | Not reported yet |
The company's wordsEdwards has increased confidence in meeting its 2026 sales growth rate guidance of 8 to 10% and EPS guidance of $2.90 to $3.05. release 2026-02-10 | |||
| Diluted EPS (company-defined) Fiscal 2026 |
Given $2.95 to $3.05 release 2026-04-23
|
– | No standard number |
The company's wordsRaising FY 2026 adjusted 2 EPS guidance midpoint; new range of $2.95 to $3.05 from $2.90 to $3.05 release 2026-04-23 | |||
| Revenue Fiscal 2026 |
Given $760.00M to $780.00M release 2026-07-23
|
– | Not reported yet |
The company's wordsBased on the company’s second quarter performance, Edwards is increasing its full-year 2026 sales growth rate guidance to 10% to 11% from 9% to 11%, TAVR product group sales growth guidance to 8% to 9% from 7% to 9%, and TMTT product group sales guidance to $760 to $780 million from $740 to $780 million. release 2026-07-23 | |||
| Diluted EPS (company-defined) Q4 of fiscal 2026 |
Given $0.61 to $0.69 release 2026-11-04
|
– | No standard number |
The company's wordsThe company is also reaffirming mid-single-digit growth guidance in Surgical. … For the fourth quarter of 2026, the company projects total sales to be between $1.67 and $1.75 billion and adjusted EPS of $0.61 to $0.69. release 2026-11-04 | |||
| Revenue Q4 of fiscal 2026 |
Given $1.67B to $1.75B release 2026-11-04
|
– | Not reported yet |
The company's wordsFor the fourth quarter of 2026, the company projects total sales to be between $1.67 and $1.75 billion and adjusted EPS of $0.61 to $0.69. release 2026-11-04 | |||
| Diluted EPS (company-defined) Q3 of fiscal 2026 |
Given $0.71 to $0.77 release 2026-07-23
|
– | No standard number |
The company's wordsFor the third quarter of 2026, the company projects total sales to be between $1.63 and $1.71 billion and adjusted EPS of $0.71 to $0.77. 4 release 2026-07-23 | |||
| Revenue Q3 of fiscal 2026 |
Given $1.63B to $1.71B release 2026-07-23
|
$1.72B 10-Q filed 2026-11-04 |
Above the range |
The company's wordsFor the third quarter of 2026, the company projects total sales to be between $1.63 and $1.71 billion and adjusted EPS of $0.71 to $0.77. 4 release 2026-07-23 | |||
| Diluted EPS (company-defined) Q2 of fiscal 2026 |
Given $0.70 to $0.76 release 2026-04-23
|
– | No standard number |
The company's wordsFor the second quarter of 2026, the company projects total sales to be between $1.66 and $1.74 billion and adjusted EPS of $0.70 to $0.76. release 2026-04-23 | |||
| Revenue Q2 of fiscal 2026 |
Given $1.66B to $1.74B release 2026-04-23
|
$1.74B 10-Q filed 2026-08-04 |
Above the range |
The company's wordsFor the second quarter of 2026, the company projects total sales to be between $1.66 and $1.74 billion and adjusted EPS of $0.70 to $0.76. release 2026-04-23 | |||
| Diluted EPS (company-defined) Q1 of fiscal 2026 |
Given $0.70 to $0.76 release 2026-02-10
|
– | No standard number |
The company's wordsFor the first quarter of 2026, the company projects total sales to be between $1.55 and $1.63 billion and adjusted EPS of $0.70 to $0.76. 3 release 2026-02-10 | |||
| Revenue Q1 of fiscal 2026 |
Given $1.55B to $1.63B release 2026-02-10
|
$1.65B 10-Q filed 2026-05-06 |
Above the range |
The company's wordsFor the first quarter of 2026, the company projects total sales to be between $1.55 and $1.63 billion and adjusted EPS of $0.70 to $0.76. 3 release 2026-02-10 | |||
| Diluted EPS (company-defined) Fiscal 2025 (ended 2025-12-31) |
Given $2.40 to $2.50 release 2025-02-11
Raised $2.56 to $2.62 release 2025-10-30
|
– | No standard number |
The company's wordsHighlights and Outlook … Reiterating 2025 constant currency sales growth of 8% - 10%; adjusted EPS of $2.40 - $2.50 release 2025-02-11 2025 Full-Year Outlook … Increasing adjusted 1 EPS guidance to $2.56 to $2.62 from the high end of $2.45 to $2.55 release 2025-10-30 | |||
| Diluted EPS (company-defined) Q2 of fiscal 2025 |
Given $0.59 to $0.65 release 2025-04-23
|
– | No standard number |
The company's wordsFor the second quarter of 2025, the company projects total sales to be between $1.45 and $1.53 billion and adjusted EPS of $0.59 to $0.65. release 2025-04-23 | |||
| Revenue Q2 of fiscal 2025 |
Given $1.45B to $1.53B release 2025-04-23
|
$1.53B 10-Q filed 2025-08-06 |
Above the range |
The company's wordsFor the second quarter of 2025, the company projects total sales to be between $1.45 and $1.53 billion and adjusted EPS of $0.59 to $0.65. release 2025-04-23 | |||
| Diluted EPS (company-defined) Q1 of fiscal 2025 |
Given $0.58 to $0.64 release 2025-02-11
|
– | No standard number |
The company's wordsFor the first quarter of 2025, the company projects total sales to be between $1.35 and $1.43 billion and adjusted EPS of $0.58 to $0.64. release 2025-02-11 | |||
| Revenue Q1 of fiscal 2025 |
Given $1.35B to $1.43B release 2025-02-11
|
$1.41B 10-Q filed 2025-05-06 |
Within the range |
The company's wordsFor the first quarter of 2025, the company projects total sales to be between $1.35 and $1.43 billion and adjusted EPS of $0.58 to $0.64. release 2025-02-11 | |||
| Diluted EPS (company-defined) Fiscal 2024 (ended 2024-12-31) |
Given $2.70 to $2.80 release 2024-02-06
Kept $2.70 to $2.80 release 2024-04-25
|
– | No standard number |
The company's wordsAdditionally, the company continues to expect full year 2024 adjusted earnings per share of $2.70 to $2.80. release 2024-02-06 The company is maintaining its full-year 2024 adjusted earnings per share guidance of $2.70 to $2.80. release 2024-04-25 | |||
| Revenue Fiscal 2024 (ended 2024-12-31) |
Given $6.30B to $6.60B release 2024-04-25
|
$5.44B 10-K filed 2025-02-28 |
Below the range |
The company's wordsOverall, given the strong first quarter performance, the company now expects full-year 2024 sales growth to be at the high end of the prior guidance of 8 to 10% and $6.3 to $6.6 billion. release 2024-04-25 | |||
| Diluted EPS (company-defined) Q2 of fiscal 2024 |
Given $0.67 to $0.71 release 2024-04-25
|
– | No standard number |
The company's wordsFor the second quarter of 2024, the company projects total sales to be between $1.62 and $1.70 billion, and adjusted EPS of $0.67 to $0.71. release 2024-04-25 | |||
| Revenue Q2 of fiscal 2024 |
Given $1.62B to $1.70B release 2024-04-25
|
$1.39B 10-Q filed 2024-07-31 |
Below the range |
The company's wordsFor the second quarter of 2024, the company projects total sales to be between $1.62 and $1.70 billion, and adjusted EPS of $0.67 to $0.71. release 2024-04-25 | |||
| Diluted EPS (company-defined) Q1 of fiscal 2024 |
Given $0.62 to $0.66 release 2024-02-06
|
– | No standard number |
The company's wordsFor the first quarter of 2024, the company projects total sales to be between $1.53 and $1.61 billion, and adjusted EPS of $0.62 to $0.66. release 2024-02-06 | |||
| Revenue Q1 of fiscal 2024 |
Given $1.53B to $1.61B release 2024-02-06
|
$1.60B 10-Q filed 2024-04-29 |
Within the range |
The company's wordsFor the first quarter of 2024, the company projects total sales to be between $1.53 and $1.61 billion, and adjusted EPS of $0.62 to $0.66. release 2024-02-06 | |||
1 target far from the company's reported total, so not compared (usually a target for one product, segment or definition)
- Revenue, Fiscal 2025 (ended 2025-12-31): said $530.00M to $550.00M, reported $6.07B. The company's words
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (12 releases since 2024-02-06), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Work on EW in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/EW/export.csv") into a cell.